Summary. Follicles were sampled at three different times after treatment with 1200 iu pregnant mares' serum gonadotrophin (PMSG) or 12 mg ovine follicle-stimulating hormone (FSH), and from untreated control animals. The meiotic status and protein synthesis of the oocyte from each follicle was determined and correlated with the intrafollicular concentration of oestradiol and progesterone. Significantly higher amounts of oestradiol were present in PMSG-treated animals at sponge withdrawal than in FSH-treated and control goats. Twenty hours later, both oestradiol and progesterone concentrations in the PMSG group were higher than those in the FSH group, and were equivalent to control animals at the onset of oestrus. At 18 h after the administration of human chorionic gonadotrophin (hCG), oestradiol decreased markedly in all three treatment groups, whereas progesterone remained significantly higher in PMSG\x=req-\ treated follicles. Although these high concentrations of intrafollicular steroids were associated with a higher incidence of premature condensation of chromatin in oocytes, the two events were not causally related. Moreover, cytoplasmic maturation was not prematurely activated in these oocytes and a changed pattern of protein synthesis was observed in oocytes from all three treatment groups after the hCG injection. Whereas disturbances in follicular steroidogenesis of oestradiol and progesterone occur in vivo in goats superovulated with PMSG, they do not underlie the premature activation of the initial stages of nuclear maturation in oocytes but are associated with normal cytoplasmic maturation.
Introduction
Superovulation of goats with pregnant mares' serum gonadotrophin (PMSG) induces premature condensation of chromatin without germinal vesicle breakdown in a significantly higher pro¬ portion of oocytes than does ovine follicle-stimulating hormone (FSH) (Kumar et al., 1990 ). This apparent abnormality in the timing of nuclear maturation occurs within 48 h of gonadotrophin treatment and is not observed in unstimulated animals. In sheep and cattle, premature activation of oocyte maturation has also been demonstrated after treatment with superovulatory doses of PMSG (Moor et al., 1985; Caliesen et al., 1986) . In both of these species, the untimely induction of nuclear and cytoplasmic maturation was associated with disturbances in the concentration of steroids in follicular fluid. In addition, altering the follicular environment by the use of inhibitors of steroidogenesis during oocyte maturation in vitro induced anomalies in the nuclear and cytoplasmic maturation of sheep oocytes which manifested as gross abnormalities at fertilization (Moor et al., 1980; Osborn & Moor, 1983a; Osborn et ai, 1986) .
It is possible, therefore, that in goats, as in cattle and sheep, abnormalities in follicular steroido¬ genesis underlie the premature condensation of chromatin observed in oocytes after superovulation with PMSG (Kumar et al., 1990) , and that these alterations in follicular steroids are also associated with premature activation of cytoplasmic maturation. The present study examined this hypothesis by comparing the nuclear and cytoplasmic maturational status of oocytes and the steroid content of fluid in follicles taken from goats superovulated with PMSG with those from unstimulated and FSH-treated animals.
Materials and Methods
The experiments were conducted in conjunction with our earlier study (Kumar et ai, 1990 ) using the same animals and experimental protocols.
Animals and treatments
Oestrus was synchronized in mature Angora Cashmere female goats with intravaginal progestagenimpregnated sponges (Repromap; Upjohn Pty Ltd, Melbourne, Australia) and animals were randomly assigned to one of three treatment groups: group I was given 1200 iu PMSG (Pregnecol; Heriot Agvet, Melbourne, Australia) intramuscularly 48 h before sponge withdrawal; group 2 was given 12 mg ovine FSH (Embryo Plus; Hamilton Artifi¬ cial Breeders, Victoria, Australia) administered intramuscularly in consecutive doses of 3, 3, 2, 2, 1 and 1 mg at intervals of 12 h, starting 48 h before sponge withdrawal; and group 3 were control animals receiving no exogenous gonadotrophins. Ovulation was synchronized in gonadotrophin-treated animals by injecting 750 iu human chorionic gonadotrophin (hCG; Chorulon; Intervet, Lyppard Chemical Co., Melbourne, Australia) intramuscularly 20 h after sponge withdrawal and in control animals at detection of oestrus, which commenced 36-41 h after sponge withdrawal.
Experiments
Ovaries were removed from animals in each treatment group at one of three times: (i) at sponge withdrawal, (ii) 20 h after sponge withdrawal and (iii) 18 h after the hCG injection. Intact nonatretic follicles were dissected from each ovary at room temperature in Dulbecco's phosphate-buffered saline (PBS), supplemented with bovine serum albumin (BSA), pyruvate, lactate, glucose and antibiotics as described previously (Kumar et ai, 1990) . Only healthy follicles > 3 mm in diameter were studied from gonadotrophin-treated animals at the time of sponge withdrawal and 20 h later; but 18 h after hCG, only those measuring > 5 mm were analysed. In each control animal, there were only one or two large healthy follicles present at each time and these measured > 5 mm in diameter.
Collection of follicular fluid from individual follicles and measurement of steroid concentrations After measuring the diameter of cleanly dissected follicles with a 1 mm division scale, each follicle was transferred to a small sterile Petri dish (tissue culture dishes; Disposable Products, South Australia) containing 1 -5 ml of BSA-free dissecting medium and incised with fine scissors to release the follicular fluid. The collapsed follicular wall was then removed and placed in a separate Petri dish containing medium supplemented with BSA. The attached cumulusoocyte complex was dissected from the thecal wall, the degree of cumulus expansion noted, and the nuclear and cytoplasmic maturational status of the oocyte determined as outlined below.
The medium containing follicular fluid was centrifuged at 800 g for 5 min to remove cellular debris and the super¬ natant stored at -80°C before analysis of oestradiol and progesterone by radioimmunoassay. Since each follicular fluid sample was collected in a standard volume of PBS, the radioimmunoassay results reflected steroid concentrations in diluted follicular fluid. To calculate the concentration of oestradiol and progesterone in the original follicular fluid, the volume of each follicle was estimated using the standard relationship between the diameter (d) measured for each follicle at dissection and the volume (V) of a sphere, whereby V = 4/3 (d/2)3.
The radioimmunoassays were conducted using test kits purchased from Farmos Diagnostica (Australian Lab. Services, Melbourne, Australia). These are designed for human serum, and therefore required validation for use with diluted goat follicular fluid.
Oestradiol assay
The antiserum to oestradiol was raised in rabbits against oestradiol-6-carboxymethoxylamine-BSA and crossreacts with 16-oxoestradiol (41%), oestrone (116%) and some other steroids (<1%). Lyophilized human serum standards containing 00, 005, 015, 0-5, 1-5, 50 and 150 nmol oestradiol l"1 after reconstitution with distilled water were used for generating the standard curve. The assay was conducted essentially as described in the kit but using volumes of reagents which were 30% of those recommended. Follicular fluid samples, where appropriate, were diluted 2 1000-fold with PBS before assay. (Fig. la) . Furthermore, the curve of serial dilution of a sample of follicular fluid with a high concentration of oestradiol also demonstrated parallelism with the standard curve obtained using the kit standards (Fig. lb) . The interassay coefficient of variation between four assays was 10-9 and 5-9% for two samples of follicular fluid containing 378-2 and 4202-9 nmol oestradiol l-1, respectively. The corresponding intraassay coefficient of variation for these two samples determined by assaying 12 times in one assay was 91 and 8-5%, respectively. The sensitivity of the assay was <005 nmol 1. 
Progesterone assay
The antiserum to progesterone was raised in rabbits against I la-hydroxyprogesterone-hemisuccinate-BSA and crossreacts with 11 ß-hydroxyprogesterone (75%), 5a-dihydroprogesterone (8-8%), 5ß-dihydroprogesterone (7-1%) and < 1 % for all other steroids tested. The kit standards were lyophilized human sera which, after reconstitution with distilled water, gave concentrations of 00, 10, 2-5, 10, 25 and 100 nmol I"1. The assay was conducted as described in the kit except that 40% of the recommended volumes of reagents were used. Where appropriate, samples of follicular fluid were diluted 2-1000 fold with PBS before assay.
Validation of the kit for use with goat follicular fluid was conducted as outlined in the oestradiol assay, using crystalline progesterone (4-pregnene-3,20-dione; Sigma Chemical Co., St Louis, USA) dissolved in progesterone-free follicular fluid to obtain the following concentrations: 00, 0-5, 10, 2-5, 100, 25 and 100 nmol 1" '. When these samples were assayed alongside the standards in the kit in the same assay, parallelism was obtained between the two standard curves (Fig. 2a) . In addition, the curve of serial dilution of a sample of follicular fluid with a high level of progesterone also showed parallelism with the standard curve generated with the kit-standards (Fig. 2b) . The interassay coefficient of variation between four assays for three follicular fluid samples containing 302-3, 780-1 and 2228-2 nmol progesterone 1_1 was 10-6, 12-3 and 91%, respectively. The corresponding intraassay coefficient of variation determined by assaying 10 times in a single assay was 15-6, 151 and 10-4%, respectively. The sensitivity of the assay was approximately 0-5 nmol 1~'.
Radiolabelling and assessment of the meiotic status of each individual oocyte
The cumulus-oocyte complex from each follicle was incubated separately at 37°C for 3 h in 25 µ of antibiotic-free dissecting medium containing 1 mCi ml-1 L-[35S]methionine (specific activity > 1000 Ci mmol" ', Amersham Labs, (Armitage & Berry, 1987) (1981) . Gels were then fixed, impregnated with 2,5-diphenyl oxazole (PPO; United Technologies, Packard, Illinois, USA), dried under vacuum and exposed to Fuji RX X-ray film at -80°C (Bonner & Laskey, 1974; Laskey & Mills, 1975) . Molecular weight determinations were made using the following as standards: phosphorylase b (94 kDa), bovine serum albumin (67 kDa), ovalbumin (43 kDa), carbonic anhydrase (30 kDa), soybean trypsin inhibitor (201 kDa) and lysozyme (14-4 kDa) (Bio-Rad Labs, Richmond, CA, USA).
Statistical analysis
The mean concentration of oestradiol and progesterone in follicular fluid between gonadotrophin-treated and control animals at the different times were compared using Student's / test.
Results

Concentration of steroids in follicular fluid
Oestradiol. At the time of sponge withdrawal, there was no significant difference in the mean concentration of oestradiol in follicular fluid from FSH-treated and control animals (Table 1) . By (Kumar et al., 1990) . In the present study, anomalies in follicular fluid steroid concentrations in follicles from PMSG-treated animals were also observed at both these times. To determine whether these abnormalities were correlated, we classified follicles within each treatment group according to the meiotic status of their oocytes (i.e. GVI or GV1I), and compared their mean follicular fluid concentration of oestradiol and progesterone (Table 2) . We have not analysed follicles removed 18 h after hCG, since by this time most oocytes had undergone germinal vesicle breakdown and there was no significant difference in the proportion at Ml-MII between these two treatment groups.
In the FSH-treated group at the time of sponge withdrawal, the mean oestradiol concentration in follicles with a normal GVI oocyte was significantly higher than in those with a GVII oocyte. However, the situation was reversed 20 h later, when follicles containing GVII oocytes had a significantly higher mean content. In the PMSG-treated group, at both times, a higher mean oestradiol concentration was observed in follicles containing GVI oocytes than follicles with GVII oocytes. However, the small number of GVI oocytes precludes any valid statistical comparison between the two types of follicle in this treatment group. There was no difference in the mean concentration of progesterone between the two types of follicle within each treatment group at both time points, even though follicles from PMSG-treated animals had a significantly higher mean content 20 h after sponge withdrawal.
These results, therefore, suggest that even though high amounts of intrafollicular steroids in PMSG-treated animals are associated with an increased incidence of premature condensation of chromatin in oocytes, the two events are not causally related. Fig. 3 ) occur at molecular weights that are similar to those reported previously in sheep oocytes (Osborn et al., 1983b (Table 3) show that, despite differences among the three treatment groups in the proportion of oocytes with premature chroma¬ tin condensation (GVII oocytes) both at the time of sponge withdrawal and 20 h later, most oocytes in each group displayed a characteristic pre-maturational pattern of protein synthesis (Fig. 4) At 18 h after injection of hCG, most follicles in all three treatment groups had low oestradiol and high progesterone concentrations, and contained oocytes that displayed a post-maturational protein pattern (Fig. 4) associated with germinal vesicle breakdown and cumulus expansion (Table 4 ). There were, however, a number of discrepancies. First, 20 
Discussion
We have shown that follicular steroidogenesis in vivo during superovulation of goats with PMSG is abnormal compared with steroidogenesis in unstimulated and FSH-treated animals. These abnormalities consisted of higher intrafollicular concentrations of oestradiol at the time of sponge withdrawal and, compared with FSH-treated animals, higher amounts of both oestradiol and pro¬ gesterone 20 h later. Moreover, it is clear that PMSG-treated follicles were primed to produce greater amounts of progesterone, since significantly higher progesterone concentrations were detected in these follicles 18 h after hCG injection than in pre-ovulatory follicles from unstimulated and FSH-treated animals. Our results, therefore, support the observation by Moor et al. (1985) that the pattern of oestradiol and progesterone secretion by cultured follicles obtained from sheep superovulated with PMSG was grossly perturbed compared to follicles derived from unstimulated and FSH-treated animals.
The mechanism by which PMSG disturbs follicular steroidogenesis in vivo is unknown. It is possible that the predominant luteinizing hormone (LH)-like activity in PMSG (Farmer & Papkoff, 1979; Henderson et al., 1990) initially activates the theca interna in follicles recruited for growth to synthesize increased amounts of androgen precursors. The high content of oestradiol in follicular fluid observed within 48 h of treatment may then result from the rapid conversion of these precursors by the aromatase enzyme system in the granulosa cells. Furthermore, the prolonged half-life of PMSG (Mclntosh et al., 1975; Schams et ai, 1978) together with the ability of oestradiol to enhance the responsiveness of granulosa cells to FSH (Richards, 1980) would allow the stimu¬ lated follicles to continue producing excessive amounts of oestradiol. This would account for the high concentration of oestradiol still present in follicles 20 h after sponge withdrawal. The need for follicles to be primed with oestradiol before FSH can increase the number of LH receptors (Richards, 1980) may explain why PMSG-treated follicles produced increased amounts of pro¬ gesterone only later during superovulation. Moreover, the induction of a larger number of LH receptors in these follicles would enable them to respond more completely to a standard dose of hCG, resulting in significantly higher intrafollicular concentrations of progesterone 18 h later.
The significance of steroids in the maturation of mammalian oocytes has been highlighted (Soupart, 1974; Thibault, 1977; Moor & Trounson, 1977; McGaughey, 1977; Moor, 1978) . In particular, altering the profile of steroids secreted by pre-ovulatory sheep follicles during in vitro maturation results in anomalies in both the nuclear and cytoplasmic maturation of oocytes that lead to problems at fertilization (Moor et al., 1980; Osborn & Moor, 1983a; Osborn et ai, 1986) . Furthermore, it is well documented that disturbances in the normal endocrine milieu occur during superovulation with PMSG (Booth et al., 1975; Jensen et al., 1982; Armstrong et ai, 1983; Caliesen et al., 1986) , and that this gonadotrophin induces premature activation of oocyte maturation in sheep and cattle (Moor et ai, 1985; Caliesen et al., 1986) . Although an association between abnor¬ malities in follicular steroidogenesis and derangements in oocyte maturation may be inferred from these studies, a direct cause and effect relationship between these two events has yet to be estab¬ lished in vivo. In our study, we have addressed this issue by relating the nuclear and cytoplasmic maturational status of individual oocytes to the steroid concentration of their follicular fluid after superovulation. Our results show that while there is a definite association between abnormalities in follicular steroidogenesis and anomalies in nuclear maturation after superovulation of goats with PMSG, the two events occur independently and are not causally related.
We have also demonstrated in this study that, despite inducing abnormalities in follicular steroidogenesis and the timing of nuclear maturation, PMSG treatment does not result in the premature activation of cytoplasmic maturation in oocytes either at the time of sponge withdrawal or 20 h later. This is contrary to the observation of Moor et al. (1985) , where 28% of follicles obtained from PMSG-treated sheep and cultured for 21 h in vitro contained oocytes in which cytoplasmic maturation had been activated. This discrepancy may be explained by differences in the experimental design and methodologies used in the two studies. In the study by Moor et al. (1985) , sheep follicles were obtained 40 h after PMSG treatment (which corresponds to the time of sponge withdrawal in our study) and were cultured for 21 h before the profiles of protein synthesis in oocytes were analysed. However, neither the cytoplasmic nor the meiotic status of these oocytes were determined before follicle culture. Nevertheless, other publications from this group have shown that oocytes from PMSG-treated sheep at the time of follicle isolation have an intact germinal vesicle and an unchanged prematurational pattern of protein synthesis (Moor & Trounson, 1977; Osborn & Moor, 1983b Nevertheless, it is clear that PMSG can still induce premature chromatin condensation in goat oocytes in vivo without germinal vesicle breakdown, although the mechanism of action is uncertain. It has been proposed that chromatin condensation may require only partial activation of the maturation-promoting factor (MPF) in oocytes, whereas its full activation is a prerequisite for nuclear membrane breakdown (Kubelka et al., 1988) . Thus the LH-like activity of PMSG may activate MPF only partially and induce chromatin condensation without further maturational change. There is some evidence to support this hypothesis. First, we have shown that increasing the level of LH bioactivity during superovulation of goats with FSH, through the administration of subovulatory doses of hCG, resulted in chromatin condensation without nuclear membrane break¬ down (Kumar et al., 1991) . Second, Bomsel-Helmreich et al. (1989) .
We therefore challenge the hypothesis proposed by Moor et al. (1985) that PMSG causes premature activation of cytoplasmic maturation in vivo and that this results in abnormally 'aged' oocytes at ovulation. However, it is possible that the abnormalities in follicular steroidogenesis associated with PMSG treatment may affect cytoplasmic maturation in oocytes and result in anomalies at fertilization.
The results of this study have also confirmed previous observations on the uncoupling of the events that occur during oocyte maturation Osborn et al., 1986 (Moor & Gandolfi, 1987) . In other instances, cumulus expansion was seen in oocytes in which neither nuclear nor cytoplasmic maturation had been activated. With a few exceptions, oestradiol and progesterone concentrations in the follicular fluid in all these cases were typical of follicles before the onset of maturation. It is thus clear that whereas oocyte maturation in goats is characterized by an orderly sequence of changes in the follicle and the cumulus-oocyte complex, some of these events can occur independently.
In conclusion, we have shown that the production of oestradiol and progesterone by ovarian follicles is markedly increased during superovulation of goats with PMSG. Nevertheless, these disturbances in follicular steroidogenesis were not causally related to the high incidence of oocytes undergoing premature condensation of chromatin in PMSG-treated animals. We have yet to deter¬ mine whether this apparent abnormality in the timing of meiotic maturation compromises the fertilization of oocytes. However, this appears unlikely since most oocytes underwent germinal vesicle breakdown following the administration of hCG, with the proportion progressing to MI-MII being similar in unstimulated and gonadotrophin-treated animals. Moreover, cytoplasmic maturation did not appear to be grossly perturbed during superovulation with gonadotrophins. It is still possible that PMSG may reduce fertilization rates through the enhanced production of steroids in the peri-ovulatory period and the postulated disturbance in gamete transport in the reproductive tract (Robinson, 1973; Trounson & Moore, 1974; Crisman et al., 1980; Evans & Armstrong, 1984) . Alternatively, PMSG may induce subtle abnormalities in the cytoplasmic matu¬ ration of goat oocytes that cannot be detected on one-dimensional protein gels but which compromise their fertilization or subsequent embryonic development.
